EWING, N.J. (AP) _ Antares Pharma Inc. (ATRS) on Tuesday reported a loss of $4.5 million in its second quarter.

On a per-share basis, the Ewing, New Jersey-based company said it had a loss of 3 cents.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 2 cents per share.

The drugmaker posted revenue of $14.2 million in the period, beating Street forecasts. Five analysts surveyed by Zacks expected $13.7 million.

The company's shares closed at $2.89. A year ago, they were trading at $3.12.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRS at https://www.zacks.com/ap/ATRS